Kobayashi Pharmaceutical Co (TSE:4967) EPS (Basic) : 円233.86 (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co EPS (Basic)?

Kobayashi Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was 円13.13. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was 円233.86.

Kobayashi Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was 円13.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円233.83.

Kobayashi Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was 円45.63. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 264.35.

During the past 12 months, Kobayashi Pharmaceutical Co's average EPS without NRIGrowth Rate was -1.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 1.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Kobayashi Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 19.90% per year. The lowest was -13.40% per year. And the median was 1.20% per year.

Kobayashi Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co EPS (Basic) Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

244.08

245.71

252.36

259.63

268.16

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															47.43	55.92	100.29	64.52	13.13

Kobayashi Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kobayashi Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(20338	-	0)	/	75.843
	=	268.16

Kobayashi Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(976	-	0)	/	74.338
	=	13.13

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円233.86

Kobayashi Pharmaceutical Co (TSE:4967) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Kobayashi Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

KOY:Germany

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines